Buy Clovis Oncology Stock | CLVS Stock Price & Latest News | Public
CLVS

Clovis Oncology

$0.00 (0.00%)Today

    About CLVS

    Clovis Oncology, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of cancer treatments. Its marketed product Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase (PARP), is offered f...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.61
    -1.21
    -1.82
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$1.00

    Actual EPS
    Q3 2020

    Stats

    Market Cap$613,89M
    Volume215,3k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$17.37
    1 Year Low$2.93
    Open$6.95
    High$6.95
    Low$5.96

    Buy any stock with any amount of money.

    Download the App
    Download the app